<DOC>
	<DOC>NCT00939042</DOC>
	<brief_summary>Study to assess the efficacy of intramyocardial bone marrow derived mononuclear cell therapy concerning left ventricular ejection fraction as measured by echocardiography.</brief_summary>
	<brief_title>Alster Stem Cells - Intramyocardial Stem Therapy</brief_title>
	<detailed_description />
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Ventricular Dysfunction</mesh_term>
	<mesh_term>Ventricular Dysfunction, Left</mesh_term>
	<criteria>LVDF &lt; 45% after timely (max. 6 hours after the onset of symptomps) successful PCI conventional therapy according to the ESC guidelines for heart failure BMI &gt; 20 and &lt; 35 PCI elder then 21 days relevant valvular disease history of stroke/multivessel disease/thromboembolic event etc. DM Type I pregancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2011</verification_date>
</DOC>